Health Canada drug identification number

DIN 02341689 — GD-DICLOFENAC/MISOPROSTOL 50 200 MCG; 50 MG

GD-DICLOFENAC/MISOPROSTOL 50 is a tablet (delayed-release) of Diclofenac / Misoprostol marketed by GENMED A DIVISION OF PFIZER CANADA ULC. The full Diclofenac / Misoprostol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02341689
Brand name
GD-DICLOFENAC/MISOPROSTOL 50
Active ingredient
Diclofenac / Misoprostol
Strength
200 MCG; 50 MG
Dosage form
TABLET (DELAYED-RELEASE)
Route
ORAL
Manufacturer
GENMED A DIVISION OF PFIZER CANADA ULC
Health Canada status
MARKETED
Drug class
NSAID with mucosal protective agent (diclofenac/misoprostol combination)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Diclofenac / Misoprostol products

DINBrandStrengthFormManufacturerStatus
01917056 ARTHROTEC 50 200 MCG; 50 MG TABLET (DELAYED-RELEASE) PFIZER CANADA ULC MARKETED
02229837 ARTHROTEC 75 200 MCG; 75 MG TABLET (DELAYED-RELEASE) PFIZER CANADA ULC MARKETED
02341697 GD-DICLOFENAC/MISOPROSTOL 75 200 MCG; 75 MG TABLET (DELAYED-RELEASE) GENMED A DIVISION OF PFIZER CANADA ULC MARKETED
02413469 PMS-DICLOFENAC-MISOPROSTOL 200 MCG; 50 MG TABLET (DELAYED-RELEASE) PHARMASCIENCE INC MARKETED
02413477 PMS-DICLOFENAC-MISOPROSTOL 75 MG; 200 MCG TABLET (DELAYED-RELEASE) PHARMASCIENCE INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.